ResMed Inc. (RMD) Stock Price Today
Aura AI Summary
Key Stats
- $31.34BMarket Cap
- 951,860Volume
- HealthSector
- $283.2852W High
- $182.8252W Low
- 52 DaysTypical Hold Time
- $30.70BEnterprise Value
- 1.18%Div Yield
- -Trading Activity
Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $283.28, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Most Recent News
Buxton Resources nears key EM target at Madman copper-gold project in Western Australia
Buxton Resources is advancing its drilling at the Madman copper-gold project in Western Australia, approaching a significant electromagnetic conductor target between 600 and 700 meters deep. The drill hole MD004DD, currently around 500 meters down, a...

Oil prices rise amid attacks by Yemen's Houthis on Saudi Arabia, raising supply disruption fears.
Oil prices increased as attacks by Yemen's Iran-backed Houthis targeted Saudi airports in Jazan and Najran, raising concerns about crude supply disruptions from the Middle East. Despite recovering supplies, including 5.8 million barrels pumped throug...

Option Care Health deal price under investigation for fairness to shareholders.
Ademi LLP is investigating the proposed $5.8 billion acquisition of Option Care Health, where shareholders will receive $32.05 per share. The investigation focuses on whether the deal price fairly values the company, the benefits to insiders, restric...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.